Inter-laboratory variation

Inter-laboratory variation refers to the differences in measurement results obtained by different laboratories when testing the same sample under similar conditions. This concept is central to ISO 5725.1:2002, which defines reproducibility as the precision of measurement when performed by different operators in different laboratories. In the context of enterprise risk management, it is a critical indicator of measurement-related risks that can impact product quality assurance, regulatory compliance, and customer trust. For companies operating in regulated industries like pharmaceuticals or medical devices, high inter-laboratory variation can lead to invalid quality-assurance data, potentially resulting in product recalls or legal challenges. This is distinct from intra-laboratory variation, which measures the precision within a single laboratory. Understanding both is essential for a robust quality management system (QMS).

Practical application involves three key steps: First, Baseline Establishment. Companies must define a reference material and conduct initial inter-laboratory comparisons to quantify existing variation levels. Second, Setting Acceptance Criteria. Based on ISO 5725.2, enterprises must define acceptable limits for reproducibility (e.g., Relative Standard Deviation < 10%). Any results exceeding these limits must trigger a formal investigation. Third, Continuous Monitoring. This involves regular participation in Proficiency Testing (PT) schemes and internal quality control audits. A real-world example is a Taiwanese electronics manufacturer that standardized its-wafer-level testing across three sites. By implementing these controls, they reduced inter-site variation by 30%, which decreased the product-rejection rate by 1.5% and saved $1.2M annually. This demonstrates how managing inter-laboratory variation directly impacts the bottom line and operational stability.

Taiwan enterprises typically face three challenges: Resource Constraints, Technical Gaps, and Regulatory Complexity. First, the cost of inter-laboratory studies can be high; the solution is to prioritize Critical Quality Attributes (CQAs) for initial implementation. Second, many technicians lack the statistical expertise required for reproducibility studies; this can be addressed through targeted training in ISO/IEC 17025 and SPC (Statistical Process Control). Third, the evolving regulatory landscape in Taiwan (TFDA) and internationally (FDA, EMA) creates confusion. The best approach is to adopt international standards as the baseline, which ensures compliance across multiple jurisdictions. A phased implementation plan—starting with a 90-day pilot program—is recommended to demonstrate ROI before scaling up company-wide.

Winners Consulting Services Co., Ltd. specializes in Inter-laboratory variation for Taiwan enterprises, delivering compliant management systems within 90 days. Free consultation: https://winners.com.tw/contact